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Abstract
Hypercalcemia may occur in hyperthyroid patients due to overactive bone 
absorption. The coexistence of hyperthyroidism and hyperparathyroidism 
is highly unusual. We herein report a 37-year-old woman who suffered 
from urolithiasis and hyperthyroidism. Further inquiry revealed that the 
patient also had parathyroid adenoma. She was successfully treated for 
euthyroidism with methimazole followed by subtotal thyroidectomy and 
parathyroidectomy for the hyperparathyroidism. We also discuss the pos-
sible conditions other than hyperthyroidism that may result in hypercal-
cemia. [Tzu Chi Med J 2010;22(4):241–243]
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1. Introduction
Hypercalcemia is common in active hyperthyroidism 
patients due to increased absorption of bone or altered 
catecholamine metabolism [1]. It returns to normo-
calcemia if thyroid function improves. However, it is 
hard to diagnose when there is concomitant hyper-
thyroidism and primary hyperparathyroidism because 
the vague symptoms of hyperthyroidism often mask 
the symptoms of hyperparathyroidism. This case re-
port calls attention to the fact that hypercalcemia in 
hyperthyroid patients may be due to coexistent dis-
eases other than hypercalcemia. Five clinical clues can 
help identify the possibility of conditions other than 
hyperthyroidism that may result in hypercalcemia.
2. Case report
A 37-year-old woman with a history of right renal 
stone received lithotripsy 1 year prior to presenting 
herself to a nephrologist due to bilateral flank pain 
in April 2009. On questioning the patient, it was 
discovered that she had had heat intolerance, irrita-
bility, insomnia and epigastric pain. On physical exami-
nation, she was 167 cm in height, 67.5 kg in weight, 
with a pulse rate of 112 bpm and a blood pressure 
of 112/74 mmHg. She had bilateral mild exophthal-
mos, lid retraction and grade 1 diffuse goiter; a finger-
tip sized nodule was detected over the left lower 
lobe. The remainder of the physical examination was 
normal.
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Laboratory investigations (Table) revealed hyper-
calcemia, hypophosphatemia, and a high intact para-
thyroid hormone level. Thyroid function was tested 
and disclosed very low thyroid-stimulating hormone 
level, and high free T4 and T3 levels. Normal findings 
were found for Na (140 mmol/L), K (3.8 mmol/L) and 
Mg (2.32 mg/dL). Liver and renal functions were also 
normal.
Thyroid ultrasonography showed a diffuse goiter 
that was consistent with Graves’ disease. However, 
there was a 1.59 × 1.37 × 0.86 cm hypoechoic mass over 
the left lower pole (Fig. 1). A technetium-99m meth-
oxyisobutylisonitrile (99mTc-MIBI) scan disclosed sig-
nificant radiotracer uptake by this nodule, indicating 
the likelihood of parathyroid tissue (Fig. 2).
The patient was subsequently treated with 20 mg 
methimazole and 1600 mg clodronate daily to control 
her hyperthyroidism and hypercalcemia over 3 months. 
At this point, the patient underwent bilateral subtotal 
thyroidectomy and removal of the parathyroid ade-
noma, which weighed 1.4 g. The pathological findings 
were diffuse hyperplasia of thyroid gland and adeno-
matous features of parathyroid tissue. Postopera-
tively, she had transient and mild hypocalcemia as 
expected. By October 2009, she was euthyroid and 
normocalcemic, both clinically and biochemically, in 
the absence of any medication.
3. Discussion
It is well known that hyperthyroidism may result in 
hypercalcemia, although typically this is mild; this is 
due to enhanced bone resorption or altered catecho-
lamine metabolism. The prevalence of hypercalcemia 
in hyperthyroid patients is estimated to be between 
17% and 22% [2–4]. We have a tendency to assume 
that slight hypercalcemia in patients with hyperthy-
roidism is actually related to the presence of excessive 
thyroid hormone. In this patient, the elevation of 
blood calcium could have been easily overlooked or as-
sumed to be secondary to hyperthyroidism, had there 
not been a past history of renal stone. Certainly, a his-
tory of urolithiasis is useful information when there 
is suspicion of hyperparathyroidism. Nevertheless, it 
is still hard to determine whether hyperthyroidism is 
concomitant with primary hyperparathyroidism based 
on clinical manifestations when it is at an early stage. 
Direct measurement of parathyroid hormone level is 
the most useful, but can be a costly laboratory param-
eter in the differential diagnosis of hypercalcemia [5]. 
In the review by Lam et al [6], thyrotoxicosis with typ-
ical symptoms appeared first in 53% of patients [7]. 
In contrast to the increased appetite and frequent 
defecation typically encountered in uncomplicated 
hyperthyroid patients, the presence of constipation, 
Table — Results of laboratory evaluation
 Reference values Results
Blood
   TSH (μIU/mL) 0.35–5.5 0.004
   Free T4 (ng/dL) 0.89–1.8 2.66
   T3 (ng/dL) 60–181 206.78
   TSH-receptor ab (%) < 15 36.9
   Anti-TPO ab (IU/mL) 0–34 592
   Anti-thyroglobulin ab (IU/mL) 0–60 162.3
   Calcium (mmol/L) 2.20–2.55 2.96
   Phosphate (mg/dL) 2.7–4.5 2.6
   Intact PTH (pg/mL) 14–72 203.5
   Magnesium (mg/dL) 1.7–2.55 2.32
   GPT (IU/L) 3–31 29
   Plasma glucose (mg/dL) 60–100 82
24-hour urine
   Epinephrine (μg) < 22.4  < 3
   Norepinephrine (μg) 11.1–85.5 17.2
   Dopamine (μg) 50–450 126.8
TSH = thyroid-stimulating hormone; ab = antibody; TPO = thyroid 
peroxidase; PTH = parathyroid hormone; GPT = glutamic-pyruvate 
transaminase.
Fig. 1 — An extrathyroid hypoechoic nodule detected over 
the left lower neck.
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Fig. 2 — Left lower parathyroid lesion detected by 99mTc-
MIBI scan.
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anorexia, and polyuria may suggest the coexistence 
of significant hypercalcemia in hyperthyroid patients. 
It should also be considered in patients with a di-
astolic blood pressure greater than 95 mmHg, which 
is secondary to hypercalcemia [2]. Therefore, hypo-
phosphatemia is probably another useful clue when 
suspecting the possibility of hyperparathyroidism in 
conjunction with hyperthyroidism [8]. Extreme hypo-
phosphatemia is present in 60% of patients with co-
existent hyperthyroidism and parathyroid adenoma 
[9]. If the patient’s serum calcium level is more than 
3.75 mmol/L (15 mg/dL) [10], then the hyperparathy-
roid hormone level should be checked, and high lev-
els of this hormone are most frequently caused by 
parathyroid adenoma. In patients with hyperthyroid-
ism and asymptomatic hypercalcemia, after 6 weeks 
of antithyroid drug treatment, 13.5% were found to 
have hypercalcemia coexistent with the primary hy-
perparathyroidism [11]. Last but not least, persistent 
hypercalcemia on restoration of euthyroidism is un-
doubtedly suggestive evidence of the presence of a 
non-thyroid-related cause of the hypercalcemia.
Since hyperthyroid-related hypercalcemia is usu-
ally mild, it was unlikely to be the cause of the above 
hypercalcemia symptoms. We would like to remind 
clinicians that it is imperative to consider that there 
may be other coexistent underlying causes of hyper-
calcemia other than hyperthyroidism-related hyper-
calcemia, as was found in our case. Five potential 
clinical clues that should lead the clinician to suspect 
the possibility of a cause other than hyperthyroidism 
when a hyperthyroid patient has hypercalcemia are:
1. symptoms or a history of urolithiasis with or with-
out profound catabolic changes to the bones;
2. presence of decreased appetite or anorexia, consti-
pation, loss of initiative and a diastolic blood pres-
sure greater than 95 mmHg in hyperthyroid patients;
3. serum calcium greater than 3.75 mmol/L;
4. extreme hypophosphatemia;
5. persistent hypercalcemia even when euthyroidism 
is restored.
Hypercalcemia is common in patients with 
active hyperthyroidism. We usually assume that mild 
hypercalcemia in hyperthyroidism will invariably nor-
malize upon restoration of euthyroidism. However, 
in some hyperthyroid patients, hypercalcemia may be 
due to a cause other than metabolic changes due to 
excessive thyroid hormone. We have provided clini-
cal and laboratory clues that will help the clinician to 
be suspicious of the possibility of coexistent condi-
tions (most frequently hyperparathyroidism) that may 
contribute to hypercalcemia in patients with an over-
active thyroid. An analysis of patient’s presenting 
symptoms, their signs, the degree of hypercalcemia, 
an assessment of the serum phosphate level and an 
analysis of the course of the hypercalcemia should 
lead to a correct diagnosis.
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